Franz B. Humer, Director at Allogene Therapeutics, Inc. (ALLO), bought 104,870 shares at $18.00 ($540K) on 2018-10-15, disclosed to the SEC on 2018-10-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 74,870 | $0 | 0.0% |
| 2 | $18.00 | 30,000 | $540K | 100.0% |
| Total | $5.15 avg | 104,870 | $540K | 100% |
| Filing → |